Recent Steering Committee decisions: updates to Medication Lists

At their April 2025 meeting, the TPP Steering Committee (TPPSC) made the following decisions:

1. Daridorexant will continue to be monitored for an additional year on the TPP Type 2 Medication List. The committee will review daridorexant in one year to assess the need for further monitoring.

2. The following medications are no longer included on the TPP Type 2 Medication List:

• Cefaclor

• Grepafloxacin

• Zaleplon

• Probuphine (brand name)

• Atasol (brand name)   

3. The following medications are no longer included on the TPP Veterinary List:

• Zaleplon

• COMPONENT E-H Implants

• Ketalean

• Demerol (brand name)

4. No changes have been made to the TPP Type 1 Medication List.